Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - OTHER CURRENT ASSETS
Other Current Assets EXEL - Exelixis, Inc.
67.9 M
LAST VALUE
8.66%
2 YEAR CAGR
8.07%
5 YEAR CAGR
14.64%
10 YEAR CAGR